Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy

Neurology

Volumn 77, Issue 22, 2011, Pages 1951-1959

  Selcen, Duygu ^a   Bromberg, Mark B ^a   Chin, Steven S ^b   Engel, Andrew G ^a  

^a Mayo Clinic College of Medicine   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FHL1 PROTEIN; LIM PROTEIN; LIM2 PROTEIN; MENADIONE; NITROBLUE TETRAZOLIUM; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CELL AGGREGATION; CELL NUCLEUS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOPLASM; DISK DIFFUSION; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; FEMALE; GENETIC POLYMORPHISM; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; JOINT CONTRACTURE; MALE; MICROTUBULE; MISSENSE MUTATION; MUSCLE; MUSCLE FIBRIL; MUSCLE HYPERTROPHY; MUSCLE RIGIDITY; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYOFIBRILLAR MYOPATHY; MYOFILAMENT; MYOPATHY; MYOTONIA; NITROBLUE TETRAZOLIUM TEST; NUCLEOTIDE SEQUENCE; PERIKARYON; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SARCOPLASMIC RETICULUM; SCHOOL CHILD; SEQUENCE ANALYSIS; SPINE;

EID: 82955228817     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823a0ebe     Document Type: Article

References (39)

1. Morgan MJ, Madgwick AJ. The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle. Biochem Biophys Res Commun 1999;255:245-250. (Pubitemid 29292244)
2. Chu PH, Ruiz-Lozano P, Zhou Q, Cai C, Chen J. Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech Dev 2000;95:259-265. (Pubitemid 30440818)
3. Ng EK, Lee SM, Li HY, et al. Characterization of tissuespecific LIM domain protein (FHL1C) which is an alternatively spliced isoform of a human LIM-only protein (FHL1). J Cell Biochem 2001;82:1-10. (Pubitemid 32500136)
4. Cowling BS, Cottle DL, Wilding BR, D'Arcy CE, Mitchell CA, McGrath MJ. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: A comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 2011;21:237-251.
5. Windpassinger C, Schoser B, Straub V, et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008;82:88-99. (Pubitemid 351726081)
6. Schessl J, Zou Y, McGrath MJ, et al. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest 2008;118:904-912. (Pubitemid 351364598)
7. Schessl J, Taratuto AL, Sewry C, et al. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain 2009;132:452-464.
8. Quinzii CM, Vu TH, Min KC, et al. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am J Hum Genet 2008;82:208-213. (Pubitemid 351726088)
9. Shalaby S, Hayashi YK, Goto K, et al. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1). Neuromuscul Disord 2008;18: 959-961.
10. Gueneau L, Bertrand AT, Jais JP, et al. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2009;85:338-353.
11. Knoblauch H, Geier C, Adams S, et al. Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation. Ann Neurol 2010;67:136-140.
12. De Bleecker JL, Engel AG, Ertl BB. Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 1996;55:563-577. (Pubitemid 26140839)
13. Nakano S, Engel AG, Waclawik AJ, Emslie-Smith AM, Busis NA. Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol 1996;55:549-562. (Pubitemid 26140838)
14. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: Clinical, morphological and genetic studies in 63 patients. Brain 2004;127:439-451. (Pubitemid 38160328)
15. Schoser B, Goebel HH, Janisch I, et al. Consequences of mutations within the C terminus of the FHL1 gene. Neurology 2009;73:543-551.
16. Engel AG. The muscle biopsy. In: Engel AG, Franzini- Armstrong C, eds. Myology, 3rd ed. New York: McGraw- Hill; 2004:681-690.
17. Wattenberg LW, Leong JL. Effects of coenzyme Q10 and menadione on succinic dehydrogenase activity as measured by tetrazolium salt reduction. J Histochem Cytochem 1960;8:296-303.
18. Brooke MH, Neville HE. Reducing body myopathy. Neurology 1972;22:829-840.
19. Way JC, Chalfie M. mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans. Cell 1988;54:5-16.
20. Freyd G, Kim SK, Horvitz HR. Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11. Nature 1990;344:876-879.
21. Karlsson O, Thor S, Norberg T, Ohlsson H, Edlund T. Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain. Nature 1990;344:879-882.
22. Schmeichel KL, Beckerle MC. Molecular dissection of a LIM domain. Mol Biol Cell 1997;8:219-230. (Pubitemid 27097939)
23. Chen DH, Raskind WH, Parson WW, et al. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: Phenotypic spectrum and structural study of FHL1 mutations. J Neurol Sci 2010;296:22-29.
24. Michelsen JW, Sewell AK, Louis HA, et al. Mutational analysis of the metal sites in an LIM domain. J Biol Chem 1994;269:11108-11113. (Pubitemid 24200315)
25. Schessl J, Columbus A, Hu Y, et al. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: Identification of a second LIM domain mutation in FHL1. Neuropediatrics 2010;41:43-46.
26. Claeys KG, Fardeau M, Schroder R, et al. Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene. Neuromuscul Disord 2008;18:656-666.
27. Selcen D. Myofibrillar myopathies. Curr Opin Neurol 2010;23:477-481.
28. Tome FM, Chateau D, Helbling-Leclerc A, Fardeau M. Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul Disord 1997; 7(suppl 1):S63-S69.
29. Calado A, Tome FM, Brais B, et al. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 2000;9:2321-2328.
30. Chou SM. Myxovirus-like structures and accompanying nuclear changes in chronic polymyositis. Arch Pathol 1968;86:649-658.
31. Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest 1971;25:240-248.
32. Sato T, Walker DL, Peters HA, Resse HH, Chou SM. Chronic polymyositis and myxovirus-like inclusions: Electron microscopic and viral studies. Arch Neurol 1971;24: 409-418.
33. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: Observations in 40 patients. Brain 1989;112:727-747. (Pubitemid 19151167)
34. Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004;62:1363-1371. (Pubitemid 38526050)
35. Erb W. Dystrophia muscularis progressiva: Klinische und pathologisch-anatomische studien. Dtsch Z Nervenheilkd 1891;1:173-261.
36. Gilchrist JM, Pericak-Vance M, Silverman L, Roses AD. Clinical and genetic investigation in autosomal dominant limb-girdle muscular dystrophy. Neurology 1988;38:5-9. (Pubitemid 18028081)
37. Hauser MA, Horrigan SK, Salmikangas P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet 2000;9:2141-2147.
38. Lacson AG, Seshia SS, Sarnat HB, et al. Autosomal recessive, fatal infantile hypertonic muscular dystrophy among Canadian Natives. Can J Neurol Sci 1994;21: 203-212. (Pubitemid 24276129)
39. Del Bigio MR, Chudley AE, Sarnat HB, et al. Infantile muscular dystrophy in Canadian aboriginals is an αBcrystallinopathy. Ann Neurol 2011;69:866-871.